DF Dent & Co. Inc. decreased its position in shares of Endava plc (NYSE:DAVA - Free Report) by 8.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 709,737 shares of the company's stock after selling 67,371 shares during the period. DF Dent & Co. Inc. owned 1.20% of Endava worth $21,931,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also made changes to their positions in the business. State Street Corp lifted its stake in Endava by 33.0% during the 3rd quarter. State Street Corp now owns 80,148 shares of the company's stock valued at $2,047,000 after acquiring an additional 19,884 shares during the period. Oppenheimer Asset Management Inc. acquired a new position in Endava during the fourth quarter worth $215,000. Robeco Institutional Asset Management B.V. raised its position in shares of Endava by 13.9% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company's stock worth $6,313,000 after purchasing an additional 25,000 shares during the last quarter. Natixis Advisors LLC raised its holdings in shares of Endava by 44.8% during the fourth quarter. Natixis Advisors LLC now owns 45,340 shares of the company's stock valued at $1,401,000 after acquiring an additional 14,023 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Endava by 35.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,289 shares of the company's stock valued at $843,000 after purchasing an additional 7,124 shares during the last quarter. 62.23% of the stock is owned by institutional investors and hedge funds.
Endava Trading Down 1.6 %
Shares of DAVA stock traded down $0.29 during trading hours on Tuesday, hitting $17.57. The company had a trading volume of 217,654 shares, compared to its average volume of 495,877. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.90 and a quick ratio of 1.90. The stock has a market capitalization of $1.04 billion, a PE ratio of 160.04, a price-to-earnings-growth ratio of 2.26 and a beta of 1.33. The company's fifty day moving average is $25.72 and its 200 day moving average is $27.32. Endava plc has a fifty-two week low of $16.70 and a fifty-two week high of $34.94.
Endava (NYSE:DAVA - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.18). The firm had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. Endava had a return on equity of 0.89% and a net margin of 0.74%. Research analysts expect that Endava plc will post 0.57 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
DAVA has been the topic of several recent research reports. Susquehanna lowered their target price on Endava from $55.00 to $50.00 and set a "positive" rating on the stock in a report on Friday, February 21st. Morgan Stanley boosted their price objective on Endava from $33.00 to $35.00 and gave the stock an "equal weight" rating in a research note on Friday, January 31st. Finally, Needham & Company LLC cut their target price on Endava from $43.00 to $38.00 and set a "buy" rating for the company in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Endava has an average rating of "Moderate Buy" and a consensus price target of $39.10.
Check Out Our Latest Analysis on DAVA
Endava Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
See Also

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.